Genmab | GEN - Ricavi Di Vendita

Prezzo Delle Azioni
1,722.00
Cambio Giornaliero
-0.50 -0.03%
Mensile
-3.01%
Annuale
23.22%
Q2 Previsione
1,604.35




I Saldi Cambiamento Data
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Almirall EUR 547.63M 12.83M 2025-12
Amarin USD 49.22M 451K 2025-12
Amgen USD 8.62B 1.28B 2026-03
argenx SE USD 1.12B 0 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bayer EUR 13.41B 1.97B 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Demant DKK 6.25B 800M 2025-12
Exelixis USD 610.8M 12.14M 2026-03
Fresenius Medical Care EUR 4.61B 460M 2026-03
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
GN Store Nord DKK 3.85B 830M 2026-03
GRIFOLS EUR 1.7B 280M 2026-03
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Insmed USD 305.96M 42.16M 2026-03
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Novartis USD 13.11B 226M 2026-03
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12